Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis ClinicalTrials.gov, 3 Dec 2013 Accessed on 25 Jun 2014 from http://www.clinicaltrials.gov/ct2/show/NCT01585766. CommentRecommendBookmarkWatch